Immunotherapy for Recurrent HNSCC – OncLive
|
Immunotherapy for Recurrent HNSCC
OncLive Therefore, the field of immunotherapy in cancer held promise that we could potentially, for a recurrent metastatic cancer patient, induce their immune system response against their cancer, providing long-term durability—the so-called tail of the curve … |
